Douglas Dolginow has stepped down from his position as senior vice president of pharmacogenomics at Gene Logic. He will continue to work at the firm on a part-time basis as a fellow and senior advisor.
Sequenom has appointed Paul Hawran to its board. Hawran, who will chair the company’s audit committee, is executive vice president and chief financial officer at Neurocrine Biosciences, which he joined in 1993.
Sequenom has also hired Michael Monko as senior vice president of sales and marketing. Monko comes to Sequenom from Upstate Chemicon where he most recently was vice president of sales. He has also had a 19-year stint with Invitrogen where he was a sales rep and later became senior director of sales force effectiveness.
Monko has an MBA from BabsonCollege and a BS in biochemistry from the University of New Hampshire.
Expression Analysis has appointed several people to its scientific advisory board: John Ryan, chief medical officer of AVEO Pharmaceuticals; Richard Hockett, medical fellow and director of genomic medicine at Eli Lilly; and Buzz Sztukowski, senior vice president of global marketing and strategic development at BioMerieux.